Antibiotics have long been a cornerstone of modern medicine, but their effectiveness is increasingly under threat. Antimicrobial resistance (AMR) is a growing global concern, fueled by natural bacterial mutations and the widespread misuse of antibiotics in both healthcare and agriculture. To stay ahead of this challenge, researchers are turning to an unexpected ally: light. Advances in photonics are offering faster diagnostics, smarter treatment strategies, and even drug-free alternatives to fight infection.
Every year from November 18–24, the World Antimicrobial Awareness Week (WAAW) raises global attention to AMR. Established by the World Health Assembly in 2015, WAAW promotes understanding of AMR and encourages best practices among the public, healthcare providers, farmers, policymakers, and other stakeholders. Its goals are clear: raise awareness of the AMR threat, promote responsible antimicrobial use, and foster collaboration across human, animal, plant, and environmental health sectors.

Faster, Smarter Diagnostics
Traditional antimicrobial susceptibility testing is slow because it relies on bacterial growth to measure resistance. Photonics is changing that paradigm. Using optical biosensors, Raman spectroscopy, and fluorescence imaging, researchers can quickly identify bacterial strains and detect resistance traits. Even more cutting-edge, photonic crystal cavities—tiny structures that trap light—are being used to hold and analyze individual bacteria. This allows scientists to monitor how a single bacterium responds to antibiotics or even bacteriophages in real time, skipping the need for lengthy culture processes. These methods can determine not only whether a treatment works, but also details like minimum inhibitory concentrations or viral burst sizes, offering unprecedented precision in susceptibility testing.
Real-Time Monitoring of Treatment
Photonics also enables continuous observation of bacterial responses. Light-based imaging can reveal when bacteria are stressed, alive, or killed by antibiotics or phages. By tracking these subtle optical “signatures,” clinicians may soon be able to tailor therapies more quickly and effectively. Machine learning tools are now being applied to interpret these signals, opening the door to rapid, automated decision-making in infection control.
Light as a Treatment Itself
Photonics is not limited to diagnostics. Light-based therapies are emerging as powerful alternatives to drugs. Photodynamic therapy, for example, uses light-activated compounds to produce reactive oxygen species that destroy bacteria. Blue and ultraviolet light have also shown promise in directly damaging bacterial DNA or disrupting cell walls. These non-drug methods could become crucial in tackling multidrug-resistant infections.
Precision Delivery of Antibiotics
Another frontier lies in drug delivery. Photonics enables controlled release of antibiotics using light-sensitive carriers, ensuring that medication is delivered exactly where it is needed. Fiber-optic sensors and surface plasmon resonance (SPR) systems are also being developed to detect antibiotic residues in food products like milk, ensuring safety and reducing unnecessary exposure to antibiotics in everyday life.
The Bigger Picture
The marriage of photonics and microbiology is creating a toolkit to combat one of the greatest health challenges of our time. By enabling rapid diagnostics, real-time monitoring, novel therapies, and improved safety measures, light is illuminating new paths forward. These technologies not only support the responsible use of antibiotics but also offer innovative alternatives when traditional drugs fall short.
Photonics will not replace antibiotics, but it is reshaping how we detect, monitor, and fight infections. In the urgent battle against antimicrobial resistance, light may prove to be one of medicine’s brightest and most versatile allies.
For further examples and research on this topic, the following IEEE articles can be referenced:
Photonic Crystal Cavities for Ultrafast Antimicrobial Susceptibility Testing at the Single-Bacterium Level, 2024 IEEE BioSensors Conference (BioSensors)
Antibiotic Monitoring Employing Raman/SERS Spectroscopy, 2024 SBFoton International Optics and Photonics Conference (SBFoton IOPC)
Optical Characterization, Discrimination and Status of Bacteria and Bacteriophages Viruses Optically Trapped in a Photonic Crystal Cavity in the Context of Phage antibiotics therapies, 2025 International Conference on Transparent Optical Networks (ICTON)
Integrated Photonic Crystal Nanotweezers for Bacteria and Bacteriophages Viruses Trapping and Susceptibility Testing, 2024 International Conference on Transparent Optical Networks (ICTON)

